University of Vermont

The University of Vermont Cancer Center

Bio for Kelly Butnor, M.D.
Kelly Butnor, M.D.

Kelly Butnor, M.D.

Associate Professor
Department of Pathology


Contact Information
E-mail: Kelly.Butnor@uvm.edu
Office Location:
EP2-120

Education

1993 Syracuse University, Syracuse, New YorkBachelor of Science in Biology, summa cum laude with Honors
1997 Duke University School of Medicine, Durham, North Carolina, Doctor of Medicine

Academic Appointments

2008 - Present Associate Professor, University of Vermont, Department of Pathology, Burlington, Vermont
2002 - 2008 Assistant Professor. University of Vermont, Department of Pathology, Burlington, Vermont

Awards and Honors

2001 - 2002 Chief Resident in Pathology, Duke University Medical Center
2002 North Carolina Society of Pathologists Resident Research Award
2002 Society for Ultrastructural Pathology Meritorious Achievement Award
1993 Syracuse University Honors Program Outstanding Undergraduate Thesis Award
1993 Phi Beta Kappa

Publications

2011 Meisinger Q, Gentchos G, Butnor KJ, Leavitt BJ, Klein JS. CT Features of Peripheral Pulmonary Carcinoid Tumors. Am J Roentgen 2011;197:1073-80

2011 Shukla A, Hillegass JM, Macpherson MB, Beuschel SL, Vacek PM, Butnor KJ, Pass HI, Carbone M, Testa JR, Heintz NH, Mossman BT. ERK2 is essential for the growth of human epithelioid malignant mesotheliomas. Int J Cancer. 2011 Sep 1;129(5):1075-86. doi: 10.1002/ijc.25763.

2011 Sabo-Attwood T, Ramos-Nino ME, Eugenia-Ariza M, Macpherson MB, Butnor KJ, Vacek PC, McGee SP, Clark JC, Steele C, Mossman BT. Osteopontin modulates inflammation, mucin production, and gene expression signatures after inhalation of asbestos in a murine model of fibrosis. Am J Pathol. 2011 May;178(5):1975-85.

2011 Hillegass JM, Blumen SR, Cheng K, MacPherson MB, Alexeeva V, Lathrop SA, Beuschel SL, Steinbacher JL, Butnor KJ, Ramos-NiƱo ME, Shukla A, James TA, Weiss DJ, Taatjes DJ, Pass HI, Carbone M, Landry CC, Mossman BT. Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapy. Int J Cancer. 2011 Jul 1;129(1):233-44. doi: 10.1002/ijc.25666

2010 Steinbacher JL, Lathrop SA, Cheng K, Hillegass JM, Butnor KJ, Kauppinen RA, Mossman BT, Landry CC. Gd-labeled microparticles in MRI: in vivo imaging of microparticles after intraperitoneal injection. Small. 2010 Dec 6;6(23):2678-82.

For a complete list of Kelly Butnor's publications, please visit PubMed.